Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes.
Publication
, Journal Article
Karachaliou, GS; Suzuki, A
Published in: Clin Liver Dis (Hoboken)
2024
Duke Scholars
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
2024
Volume
23
Issue
1
Start / End Page
e0121
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Karachaliou, G. S., & Suzuki, A. (2024). Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes. Clin Liver Dis (Hoboken), 23(1), e0121. https://doi.org/10.1097/CLD.0000000000000121
Karachaliou, Georgia Sofia, and Ayako Suzuki. “Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes.” Clin Liver Dis (Hoboken) 23, no. 1 (2024): e0121. https://doi.org/10.1097/CLD.0000000000000121.
Karachaliou GS, Suzuki A. Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes. Clin Liver Dis (Hoboken). 2024;23(1):e0121.
Karachaliou, Georgia Sofia, and Ayako Suzuki. “Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes.” Clin Liver Dis (Hoboken), vol. 23, no. 1, 2024, p. e0121. Pubmed, doi:10.1097/CLD.0000000000000121.
Karachaliou GS, Suzuki A. Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes. Clin Liver Dis (Hoboken). 2024;23(1):e0121.
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
2024
Volume
23
Issue
1
Start / End Page
e0121
Location
United States